🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Latanoprost-timolol maleate fixed combination ophthalmic solution

Found 18 matching trials

24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension

PHASE4

This study was designed to compare the 24-hour efficacy on intra ocular pre...

Status

Completed

Location

University Eye Clinic

Start Date

2002-01

Trial ID

NCT01655758

Treatments Being Tested

0.5% timolol timolol-dorzolamide fixed combination Latanoprost Travoprost Bimatoprost

Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients

PHASE3

The objective of the study is to assess the efficacy and safety of T2347 (L...

Status

Completed

Location

Laboratoires Thea

Start Date

2014-12

Trial ID

NCT02278614

Treatments Being Tested

T2347 Xalacom

Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma

To prove the non-inferiority of the fixed timolol-dorzolamide combination (...

Status

Completed

Location

Seoul St. Mary's hospital

Start Date

2011-03

Trial ID

NCT01175902

Treatments Being Tested

dorzolamide/timolol latanoprost

Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma

PHASE4

Glaucoma is one of the leading causes of blindness worldwide that is a chro...

Status

Completed

Location

Multiple Locations

Start Date

2014-01

Trial ID

NCT03966560

Treatments Being Tested

Brimonidine Tartrate Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol Maleate) 5 Mg/mL Eye Drops Brinzolamide/Timolol 10 MG/1 ML-5 MG/1 ML Ophthalmic Suspension Travoprost and Timolol Bimatoprost and Timolol Latanoprost

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

PHASE4

The purpose of this study is to compare the short-term mean 24-hour intraoc...

Status

Completed

Location

Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital

Start Date

2006-04

Trial ID

NCT00330577

Treatments Being Tested

timolol maleate 0.5%latanoprost/timolol fixed combination placebo (artificial tears)

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

N/A

The objective of this Investigation is to evaluate the safety and efficacy ...

Status

Completed

Location

Multiple Locations

Start Date

2010-10

Trial ID

NCT01191008

Treatments Being Tested

Latanoprost-timolol maleate fixed combination ophthalmic solution

A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma

PHASE4

Hypothesis: * H1: Efficacy of Duotrav will be superior to Xalacom at 24 ho...

Status

Completed

Location

Ophthalmic Consultant Centres

Start Date

2009-01

Trial ID

NCT00887029

Treatments Being Tested

DuoTrav (travoprost-timolol ophthalmic drops)Xalacom (latanoprost-timolol ophthalmic drops)

24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations

PHASE4

The primary objective of this crossover trial is to compare the 3-month mea...

Status

Completed

Location

Glaucoma Unit, A University Dept of Ophthalmology

Start Date

2006-09

Trial ID

NCT00397241

Treatments Being Tested

Drug: dorzolamide/timolol Drug: latanoprost/timolol dorzolamide/timolol and latanoprost placebo (artificial tears)

An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects

PHASE4

A three-month evaluation comparing the safety and efficacy of a fixed combi...

Status

Completed

Location

Multiple Locations

Start Date

2008-12

Trial ID

NCT00811564

Treatments Being Tested

fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution latanoprost 0.005%

24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.

PHASE4

This is a phase IV, interventional, multi-center, open clinical Trial. Pati...

Status

Unknown

Location

ASST Santi Paolo e Carlo

Start Date

2020-06-04

Trial ID

NCT05299593

Treatments Being Tested

tafluprost/timolol

Previous Next